Premium
Multimodality treatment of intrahepatic cholangiocarcinoma: A review
Author(s) -
Simo Kerri A.,
Halpin Laura E.,
McBrier Nicole M.,
Hessey Jacob A.,
Baker Erin,
Ross Samuel,
Swan Ryan Z.,
Iannitti David A.,
Martinie John B.
Publication year - 2016
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24093
Subject(s) - medicine , multimodality , intrahepatic cholangiocarcinoma , general surgery , radiology , world wide web , computer science
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes. J. Surg. Oncol. 2016;113:62–83 . © 2016 Wiley Periodicals, Inc.